CPSI Biotech (CPSI) is a medical technology development company. It carries out the development and design of life science research products and cryo-medical devices. The company also offers contract research services, licensing or salesin support of diverse clinical and research applications, devices and intellectual property for commercialization ventures among others. Its products find their application in cancer, cardiovascular disease treatments and cell therapy bioprocessing. CPSI is headquartered in Owego, New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company CPSI Biotech
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
CPSI Biotech Company Overview
CPSI Biotech Company Snapshot
CPSI Biotech Pipeline Products and Ongoing Clinical Trials Overview
CPSI Biotech – Pipeline Analysis Overview
CPSI Biotech - Key Facts
CPSI Biotech - Major Products and Services
CPSI Biotech Pipeline Products by Development Stage
CPSI Biotech Pipeline Products Overview
CryoInject
CryoInject Product Overview
CryoPellet
CryoPellet Product Overview
FACSGuard
FACSGuard Product Overview
FrostBite
FrostBite Product Overview
FrostBite-BC
FrostBite-BC Product Overview
ICEolate Catheter
ICEolate Catheter Product Overview
ICEolate Catheter With Spot Ablation Tip
ICEolate Catheter With Spot Ablation Tip Product Overview
ICEolate Surgical Probe With Control Handle
ICEolate Surgical Probe With Control Handle Product Overview
ICEolate Surgical Probe With Flexible Ablation Tip
ICEolate Surgical Probe With Flexible Ablation Tip Product Overview
Pressurized Sub-Cooled Nitrogen System
Pressurized Sub-Cooled Nitrogen System Product Overview
May 19, 2022: CPSI pilots clinical lens to ease provider data burdens
Aug 05, 2020: CPSI aligns with Google Cloud to support innovation and enhance product delivery and performance
Jul 08, 2020: New innovations from American HealthTech enhance decision making within clinical workflow and allow for faster communication to facility residents and family members
Oct 16, 2019: CPSI partners with customers to lower costs, improve operations and increase revenue With nTrust Program
Mar 19, 2018: In vitro study details the increased performance and potential of CPSI’s Supercritical Nitrogen cryoablation device for the epicardial based ablation of cardiac tissue
Jan 12, 2018: In Vitro study shows combinatorial ablative strategies yield improved destruction of pancreatic cancer cells
Sep 12, 2017: CPSI Biotech receives multi-year Phase II grant from the National Cancer Institute to develop FrostBite Cryoablation Technology for the Treatment of Pancreatic Cancer